Al in Omics Studies Market Beyond Big Data: AI Algorithms Deciphering the Omics Code AI in Precision Medicine

Global Al in Omics Studies Market Worth $5.44 Bn by 2031 – Exclusive Report by InsightAce Analytic Pvt. Ltd.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Al in Omics Studies Market- (By Offering (Software, Services), By Technology Platform (Sequencing, Epigenomics, Proteomics, Metabolomics, Others), By Application (Oncology, Infectious Diseases, Neurology, Cardiovascular Diseases, Immunology, Others), By End User (Academic and Research Institutes, Biopharmaceutical Company, Others)) Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”

According to the latest research by InsightAce Analytic, the Global Al in Omics Studies Market is valued at US$ 633.46 Mn in 2023, and it is expected to reach US$ 5,445.6 Mn by 2031, with a CAGR of 31.2% during the forecast period of 2024-2031.

Get a free sample copy of the report: https://www.insightaceanalytic.com/request-sample/2363

Redundancy: The sentence about analyzing omics data can be shortened to avoid repetition.

Market Growth: Consider rephrasing the sentence about market growth for better readability.

Here’s the revised version:

AI Revolutionizes Omics Research

Artificial intelligence (AI) is a powerful tool for unlocking the secrets hidden within omics data. Omics studies encompass various fields like genomics, proteomics, and metabolomics, each generating massive datasets.

AI excels at analyzing these complex datasets, helping researchers:

• Identify patterns and trends in omics data that might be missed by traditional methods.

• Predict biomarkers associated with specific diseases, leading to earlier diagnosis and treatment.

• Gain novel biological insights that can improve our understanding of health and disease.

These advancements in omics research, fueled by AI, have led to significant progress in several scientific fields:

• Medication development: AI accelerates drug discovery by identifying potential drug targets and predicting their effectiveness.

• Disease diagnosis: AI algorithms can analyze omics data to improve disease diagnosis accuracy and personalize treatment plans.

• Protein structure prediction: AI can predict protein structures, aiding in the development of new drugs and therapies.

• Genetic variation interpretation: AI helps researchers understand the functional impact of genetic variations, leading to personalized medicine approaches.

The Global AI in Omics Research Market: Growth and Potential

The global market for AI in omics research is expected to experience significant growth over the forecast period. This growth is primarily driven by the:

• Ability of AI to analyze complex omics data: Traditional methods struggle with the vast amount of data generated by omics studies.

AI offers powerful tools to analyze this data efficiently and extract valuable insights.

• Increasing investments in AI technologies: Both private and public sectors are investing heavily in AI research and development, leading to the creation of more sophisticated AI tools for omics research.

• Supportive regulatory frameworks: Governments are increasingly recognizing the potential of AI in healthcare and are developing regulations that encourage responsible AI development and implementation.

By revolutionizing omics research, AI has the potential to transform the healthcare industry. As the field progresses, we can expect even more advancements in disease diagnosis, drug discovery, and personalized medicine, ultimately leading to improved patient outcomes.

List of Prominent Players in the Al in Omics Studies Market

• GE Healthcare

• Amazon Web Services, Inc

• Bruker

• Danaher

• Thermo Fisher Scientific.

• Agilent Technologies

• Illumina

• BGI Genomics

• Dassault Systemes

• Qiagen

• Waters Corporation

• Other Prominent Players

Market Dynamics:

Drivers-

One of the main factors propelling AI in the omics studies market is its enormous potential to revolutionise genomics studies and healthcare. The market for omics studies is seeing an increase in AI due to a number of factors. First, as omics data grows in volume and complexity, sophisticated analytics tools are needed.

AI is excellent at processing, analysing, and deriving valuable insights from this data. Second, AI-driven methods for omics-based biomarker identification and medication development are required due to the growing need for tailored medicine and focused therapeutics. Thirdly, partnerships between academic, business, and medical facilities encourage creativity and accelerate the use of AI in omics studies.

Challenges:

The primary obstacles that AI in the omics studies sector must overcome are concerns about data privacy and security. The market development may be hampered by the requirement for more qualified Al experts and a strict regulatory environment.

The growing need for Al in many industries, such as genomics, presents formidable obstacles due to the scarcity of Al-versed professionals, impeding market expansion. Due to the intricacy of Al technologies and their use in genomics, a certain set of skills still needs to be improved. This scarcity impedes the smooth incorporation of Al into genomics procedures and decelerates the sequence of progress in the area. Adopting and utilising Al in genomics would also be difficult due to the strict laws controlling data security, privacy, and ethical issues.

Regional Trends:

In 2023, due to the presence of several industry participants, such as Google Health, Danone, Abbott, Nestlé, IBM, Targeted Medical Pharma, Inc., LLC, and others, North America held the bulk of the worldwide AI in omics market share of approximately

in terms of revenue. Some of the biggest and best-funded research institutes and biotechnology firms in the world are based in North America, and these organisations are actively investing in the development of AI-powered genomics solutions. This helps to fuel AI’s expansion in North America’s genomics business. It is anticipated that the industry would develop significantly overall in Asia Pacific. The region’s enormous population, growing emphasis on precision medicine and genomics technology, and fast rising healthcare costs are driving demand for AI in genomics.

Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/2363

Recent Developments:

• In November 2023, biotechnology companies OWKIN and 10x Genomics, Inc., jointly announced that they have reached an agreement to incorporate 10x Genomics’ single-cell and spatial omics technologies to their work in tumour investigation for potential therapeutic targets.

• In September 2023, Janssen Global Services, LLC, a pharmaceutical firm, and Intelligent OMICS Ltd., a biotechnology company, agreed to a partnership in AI-driven research. The goal of the partnership with Janssen Global Services, LLC is to identify new biological targets that can be used to treat haematological malignancies.

• in June 2022, the Ultima Genomics firm and Nvidia announced that they are partnering to separate AI at various stages of the DNA sequencing and analysis process. Accelerating variant calling and deep learning in photometry and base calling are two aspects of the relationship.

Segmentation of Al in Omics Studies Market –

By Offering:

• Software

• Services

By Technology Platform:

• Sequencing

• Epigenomics

• Proteomics

• Metabolomics

• Others (Transcriptomics, among others)

By Application:

• Oncology

• Infectious Diseases

• Neurology

• Cardiovascular Diseases

• Immunology

• Others (Pharmacogenomics, among others)

By End User:

• Academic and Research Institutes

• Biopharmaceutical Company

• Others (Contract Research Organizations, among others)

By Region-

North America-

• The US

• Canada

• Mexico

Europe-

• Germany

• The UK

• France

• Italy

• Spain

• Rest of Europe

Asia-Pacific-

• China

• Japan

• India

• South Korea

• Southeast Asia

• Rest of Asia Pacific

Latin America-

• Brazil

• Argentina

• Rest of Latin America

Middle East & Africa-

• GCC Countries

• South Africa

• Rest of Middle East and Africa

For More Customization @ https://www.insightaceanalytic.com/customisation/2363

Contact Us:

InsightAce Analytic Pvt. Ltd.

Tel.: +1 718 593 4405

Email: info@insightaceanalytic.com

Site Visit: www.insightaceanalytic.com

Follow Us on LinkedIn @ bit.ly/2tBXsgS

Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.

Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.

We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.

Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.